The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis
- 31 July 2007
- journal article
- Published by Elsevier BV in Trends in Immunology
- Vol. 28 (7), 299-307
- https://doi.org/10.1016/j.it.2007.05.007
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesisAmerican Journal of Physiology-Cell Physiology, 2007
- A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate CancerCancer Research, 2007
- Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agentsPeptide Science, 2006
- Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100Blood, 2006
- G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanismBlood, 2006
- Tumor Stromal-Derived Factor-1 Recruits Vascular Progenitors to Mitotic Neovasculature, where Microenvironment Influences Their Differentiated PhenotypesCancer Research, 2006
- Stromal cell-derived factor 1 (CXCL12) binds to endothelial cells and signals through a receptor different from CXCR4Biochemical and Biophysical Research Communications, 2006
- A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentThe Journal of Experimental Medicine, 2006
- Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytesNature Medicine, 2006
- Platelets secrete stromal cell–derived factor 1α and recruit bone marrow–derived progenitor cells to arterial thrombi in vivoThe Journal of Experimental Medicine, 2006